High Dietary Fat Consumption Impairs Axonal Mitochondrial Function In Vivo
Marija Sajic1, Amy E Rumora2, Anish A Kanhai3
1Department of Neuroinflammation, UCL Queen Square Institute of Neurology, London, WC1N 3BG, United Kingdom m.sajic@ucl.ac.uk.
Summary
High-fat diets impair mitochondrial function in sensory neurons, leading to peripheral neuropathy (PN) in prediabetes. This study reveals early axonal changes, including impaired energy supply and calcium imbalance, contributing to PN pathogenesis.
Area of Science:
- Neuroscience
- Metabolic Disorders
- Mitochondrial Biology
Background:
- Peripheral neuropathy (PN) is a common complication of prediabetes and type 2 diabetes (T2D).
- PN pathogenesis in T2D and prediabetes is linked to dyslipidemia, but molecular mechanisms remain unclear.
- Sensory neurons depend on axonal mitochondria for energy; dyslipidemia can cause mitochondrial dysfunction.
Purpose of the Study:
- To investigate the effects of diet-induced dyslipidemia on mitochondrial function and dynamics in sensory axons.
- To identify *in vivo* mitochondrial alterations correlating with prediabetic peripheral neuropathy.
Main Methods:
- Utilized a high-fat diet (HFD)-fed murine model of prediabetes.
- Evaluated mitochondrial membrane potential (MMP), axonal impulse conduction, and Ca2+ levels in saphenous nerve sensory axons.
- Assessed mitochondrial morphology and PGC1α expression.
Main Results:
- HFD decreased axonal mitochondrial membrane potential (MMP) and impaired nerve impulse conduction.
- HFD-induced mitochondria showed reduced MMP dissipation in response to increased energy demand, indicating loss of reserve capacity.
- HFD decreased axonal Ca2+ levels and increased mitochondrial lengthening and PGC1α expression.
Conclusions:
- Mitochondrial dysfunction contributes to axonal energy and Ca2+ imbalance in prediabetic PN.
- Impaired mitochondrial function and altered axonal energy homeostasis are early pathogenic events in PN.
- Findings provide insights into PN mechanisms associated with prediabetes and dyslipidemia *in vivo*.


